COVID-19 associated pulmonary embolism with D-dimer values within the referent range: a case report and review of the literature

Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7971-7975. doi: 10.26355/eurrev_202112_27647.

Abstract

Objective: COVID-19 is associated with an increased incidence of pulmonary embolism (PE). Elevated D-dimer levels are linked to an increased risk of PE and poor clinical outcome. We reported a case of PE in a COVID-19 patient with normal D-dimer levels and conducted a review of the literature on the subject.

Case report: A 38-year-old man with no prior comorbidities returned to the COVID-19 outpatient clinic 36 hours after being discharged from the hospital, where he had been treated for COVID-19 pneumonia. He reported a sudden feeling of dyspnea and chest pain. The physical examination was unremarkable. No new changes were detected on the chest X-ray. D-dimer and cardiac-specific markers values were within the referent range. The patient underwent an urgent computerized tomography pulmonary angiography which revealed signs of bilateral arterial thrombosis. He was treated with a therapeutic dose of low molecular weight heparin and discharged after 15 days, with a recommendation to use a direct oral anticoagulant.

Conclusions: Healthcare professionals should be aware that PE can occur as a late complication of COVID-19. Clinical suspicion of PE should lead physicians to use additional diagnostic methods to confirm or rule out PE, even if D-dimer levels are within the referent range.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / immunology
  • COVID-19 / virology
  • Chest Pain / blood
  • Chest Pain / diagnosis*
  • Chest Pain / drug therapy
  • Chest Pain / epidemiology
  • Computed Tomography Angiography
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Humans
  • Incidence
  • Lung / blood supply
  • Lung / diagnostic imaging
  • Male
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis*
  • Pulmonary Embolism / drug therapy
  • Pulmonary Embolism / epidemiology
  • Reference Values
  • SARS-CoV-2 / isolation & purification
  • Treatment Outcome

Substances

  • Fibrin Fibrinogen Degradation Products
  • Heparin, Low-Molecular-Weight
  • fibrin fragment D